From cholesterol regulation to tumor suppression: Pcsk9 as a novel target for cancer immunotherapy.

被引：0
|
作者：
Bao, Xuhui [1 ]
Liu, Xinjian [2 ]
Hu, Mengjie [1 ]
Chang, Hanman [1 ]
Jiao, Meng [1 ]
Cheng, Jin [3 ]
Xie, Liyi [4 ]
Huang, Qian [3 ]
Li, Fang [1 ]
Li, Chuan-Yuan [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
[2] Sun Yat Sen Univ, Sch Med, Shenzhen, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Shanghai, Peoples R China
[4] Fudan Univ, Shanghai Canc Ctr, Shanghai, Peoples R China
来源：
CANCER RESEARCH | 2021年 / 81卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
NG12
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Proprotein Convertase Subtilisin Kexin9 (PCSK9): A Novel Target For Cholesterol Regulation
    Basak, Ajoy
    Palmer-Smith, Heather
    Mishra, Priyambada
    [J]. PROTEIN AND PEPTIDE LETTERS, 2012, 19 (06): : 575 - 585
  • [2] PCSK9, a novel target for lowering LDL cholesterol: promise and progress
    Tavori, Hagai
    Fazio, Sergio
    Linton, MacRae F.
    [J]. CLINICAL LIPIDOLOGY, 2012, 7 (06) : 611 - 615
  • [3] The multifaceted role of PCSK9 in cancer pathogenesis, tumor immunity, and immunotherapy
    Hsu, Chou-Yi
    Abdulrahim, Mustafa Nasrat
    Mustafa, Mohammed Ahmed
    Omar, Thabit Moath
    Balto, Franklin
    Pineda, Indira
    Khudair, Teeba Thamer
    Ubaid, Mohammed
    Ali, Mohammed Shnain
    [J]. MEDICAL ONCOLOGY, 2024, 41 (08)
  • [4] PCSK9: Regulation and Target for Drug Development for Dyslipidemia
    Burke, Amy C.
    Dron, Jacqueline S.
    Hegele, Robert A.
    Huff, Murray W.
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 57, 2017, 57 : 223 - 244
  • [5] PCSK9 and LDL cholesterol: unravelling the target to design the bullet
    Costet, Philippe
    Krempf, Michel
    Cariou, Bertrand
    [J]. TRENDS IN BIOCHEMICAL SCIENCES, 2008, 33 (09) : 426 - 434
  • [6] Potential of PCSK9 as a new target for the management of LDL cholesterol
    Mombelli, Guiliana
    Castelnuovo, Samuela
    Pavanello, Chiara
    [J]. RESEARCH REPORTS IN CLINICAL CARDIOLOGY, 2015, 6 : 73 - 86
  • [7] Therapies That Target PCSK9 Effective at Reducing LDL Cholesterol
    不详
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2017, 317 (20): : 2054 - 2054
  • [8] PCSK9 in cholesterol metabolism: from bench to bedside
    Reiss, Allison B.
    Shah, Neal
    Muhieddine, Dalia
    Zhen, Juan
    Yudkevich, Jennifer
    Kasselman, Lora J.
    DeLeon, Joshua
    [J]. CLINICAL SCIENCE, 2018, 132 (11) : 1135 - 1153
  • [9] PCSK9—an exciting target for reducing LDL-cholesterol levels
    D. John Betteridge
    [J]. Nature Reviews Endocrinology, 2013, 9 : 76 - 78
  • [10] Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
    Catarina R. Almeida
    Beatriz H. Ferreira
    Iola F. Duarte
    [J]. Signal Transduction and Targeted Therapy, 6
12345